Bank of New York Mellon Corp - CABALETTA BIO INC ownership

CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 65 filers reported holding CABALETTA BIO INC in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CABALETTA BIO INC
ValueSharesWeighting
Q3 2023$2,214,008
+36.9%
145,467
+16.1%
0.00%
Q2 2023$1,617,572
+659.9%
125,296
+386.8%
0.00%
Q1 2023$212,878
-10.6%
25,7410.0%0.00%
Q4 2022$238,104
+1884.2%
25,741
+36.8%
0.00%
Q3 2022$12,000
-40.0%
18,8220.0%0.00%
Q2 2022$20,000
-56.5%
18,822
-17.0%
0.00%
Q1 2022$46,000
+17.9%
22,674
+120.2%
0.00%
Q4 2021$39,000
-68.8%
10,2950.0%0.00%
Q3 2021$125,000
+40.4%
10,2950.0%0.00%
Q2 2021$89,000
-84.2%
10,295
-79.7%
0.00%
Q1 2021$563,000
-8.9%
50,730
+2.4%
0.00%
Q4 2020$618,000
+10.8%
49,558
-3.8%
0.00%
Q3 2020$558,000
+14.1%
51,507
+17.6%
0.00%
Q2 2020$489,000
+217.5%
43,816
+108.1%
0.00%
Q1 2020$154,000
-12.5%
21,051
+67.6%
0.00%
Q4 2019$176,00012,5610.00%
Other shareholders
CABALETTA BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 2,106,000$32,053,32021.20%
COMMODORE CAPITAL LP 2,525,753$38,441,9614.49%
Bain Capital Life Sciences Investors, LLC 2,000,000$30,440,0003.40%
VR Adviser, LLC 1,973,253$30,032,9113.16%
Cormorant Asset Management, LP 2,879,424$43,824,8332.56%
Velan Capital Investment Management LP 150,000$2,283,0001.84%
Redmile Group, LLC 1,774,252$27,004,1151.28%
TCG Crossover Management, LLC 486,795$7,409,0201.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,340,118$35,616,5960.78%
Integral Health Asset Management, LLC 330,000$5,022,6000.70%
View complete list of CABALETTA BIO INC shareholders